Andrew S. Judd

1.3k total citations
25 papers, 557 citations indexed

About

Andrew S. Judd is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Andrew S. Judd has authored 25 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Organic Chemistry and 2 papers in Surgery. Recurrent topics in Andrew S. Judd's work include Chemical Synthesis and Analysis (5 papers), Synthetic Organic Chemistry Methods (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Andrew S. Judd is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Synthetic Organic Chemistry Methods (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Andrew S. Judd collaborates with scholars based in United States, United Kingdom and Canada. Andrew S. Judd's co-authors include Stephen F. Martin, Andrew J. Souers, Philip R. Kym, Irini Akritopoulou‐Zanze, Stevan W. Djurić, Rodger F. Henry, David N. Whittern, Thomas R. Hoye, Trevor F. Moraes and Hing L. Sham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Blood.

In The Last Decade

Andrew S. Judd

24 papers receiving 533 citations

Peers

Andrew S. Judd
John A. Wos United States
Ronald G. Sherrill United States
Weixu Zhai United States
Rachel A. Jones United States
Ky-Youb Nam South Korea
Robert G. Gentles United States
Susan Y. Tamura United States
Roger V. Bonnert United Kingdom
Andrea M. Sefler United States
John A. Wos United States
Andrew S. Judd
Citations per year, relative to Andrew S. Judd Andrew S. Judd (= 1×) peers John A. Wos

Countries citing papers authored by Andrew S. Judd

Since Specialization
Citations

This map shows the geographic impact of Andrew S. Judd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Judd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Judd more than expected).

Fields of papers citing papers by Andrew S. Judd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew S. Judd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Judd. The network helps show where Andrew S. Judd may publish in the future.

Co-authorship network of co-authors of Andrew S. Judd

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew S. Judd. A scholar is included among the top collaborators of Andrew S. Judd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew S. Judd. Andrew S. Judd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Darren C., Cory Alvey, Justin P. Ingram, et al.. (2024). Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2. Blood. 144(Supplement 1). 4966–4966. 1 indexed citations
2.
Sorensen, Bryan K., Roberto M. Risi, Michael L. Curtin, et al.. (2023). Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467. The Journal of Organic Chemistry. 88(22). 15562–15568. 3 indexed citations
3.
Tao, Zhi‐Fu, Xilu Wang, Jun Chen, et al.. (2021). Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor. ACS Medicinal Chemistry Letters. 12(6). 1011–1016. 14 indexed citations
4.
Hooda, Yogesh, Christine Chieh-Lin Lai, Andrew S. Judd, et al.. (2016). Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria. Nature Microbiology. 1(4). 16009–16009. 57 indexed citations
5.
Judd, Andrew S., et al.. (2016). Disseminated Fusarium in a Patient With Acute Myeloid Leukemia. CHEST Journal. 150(4). 395A–395A.
6.
Calmettes, Charles, Andrew S. Judd, & Trevor F. Moraes. (2015). Structural Aspects of Bacterial Outer Membrane Protein Assembly. Advances in experimental medicine and biology. 883. 255–270. 6 indexed citations
7.
King, Andrew, Andrew S. Judd, & Andrew J. Souers. (2009). Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents. Expert Opinion on Therapeutic Patents. 20(1). 19–29. 21 indexed citations
8.
Judd, Andrew S., Andrew J. Souers, & Philip R. Kym. (2008). Lead Optimization of Melanin Concentrating Hormone Receptor 1 Antagonists with low hERG Channel Activity. Current Topics in Medicinal Chemistry. 8(13). 1152–1157. 3 indexed citations
9.
Kym, Philip R., Andrew S. Judd, J.A. Lynch, et al.. (2007). Lead Optimization Strategies and Tactics Applied to the Discovery of Melanin Concentrating Hormone Receptor 1 Antagonists. Current Topics in Medicinal Chemistry. 7(15). 1471–1488. 5 indexed citations
10.
Zhao, Gang, Andrew S. Judd, Barbara L. Cool, et al.. (2007). Discovery and SAR development of thienopyridones: A class of small molecule AMPK activators. Bioorganic & Medicinal Chemistry Letters. 17(12). 3254–3257. 31 indexed citations
11.
Judd, Andrew S., et al.. (2007). Concise Construction of Novel Bridged Bicyclic Lactams by Sequenced Ugi/RCM/Heck Reactions. Organic Letters. 9(24). 5119–5122. 82 indexed citations
12.
HIDA, TSUNEAKI, Anne Hodgson, Andrew S. Judd, et al.. (2007). Total synthesis of erythromycin B. Tetrahedron. 63(26). 5709–5729. 38 indexed citations
13.
Judd, Andrew S. & Daene C. McKinney. (2006). Dam re-operation: Influences on natural and productive river processes (Glen Canyon and Green River Dams). Texas ScholarWorks (Texas Digital Library). 6(4). 1–44. 1 indexed citations
14.
Souers, Andrew J., Ju Gao, Dariusz Wódka, et al.. (2005). Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 15(11). 2752–2757. 35 indexed citations
15.
Souers, Andrew J., Ju Gao, Michael E. Brune, et al.. (2005). Identification of 2-(4-Benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an Orally Efficacious Melanin-Concentrating Hormone Receptor 1 Antagonist for the Treatment of Obesity. Journal of Medicinal Chemistry. 48(5). 1318–1321. 75 indexed citations
16.
Hergenrother, Paul J., Anne Hodgson, Andrew S. Judd, Wen‐Cherng Lee, & Stephen F. Martin. (2003). An Abiotic Strategy for the Enantioselective Synthesis of Erythromycin B. Angewandte Chemie International Edition. 42(28). 3278–3281. 20 indexed citations
17.
Hergenrother, Paul J., Anne Hodgson, Andrew S. Judd, Wen‐Cherng Lee, & Stephen F. Martin. (2003). An Abiotic Strategy for the Enantioselective Synthesis of Erythromycin B. Angewandte Chemie. 115(28). 3400–3403. 5 indexed citations
18.
Judd, Andrew S., et al.. (1998). Otteliones A and B:  Potently Cytotoxic 4-Methylene-2-cyclohexenones from Ottelia alismoides. The Journal of Organic Chemistry. 63(23). 8102–8106. 35 indexed citations
19.
Port, Jennifer, et al.. (1997). Thermochemistry of Oxo Transfer from Coordinated Nitrite in the Dinitro(5,10,15,20-tetrakis(o-pivalamidophenyl)porphinato)iron(III) Anion. Inorganic Chemistry. 36(9). 1904–1911. 15 indexed citations
20.
Chenier, Philip J., Andrew S. Judd, Tami L. Raguse, & Thomas R. Hoye. (1997). Chiral tropocoronands: Synthesis and metal complex formation. Tetrahedron Letters. 38(42). 7341–7344. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026